• Listed Companies
  • Circulars
  • EN
  • 繁
  • 简
  • Apr 25, 2025
    17:05

    Notification Letter and Reply Form to Registered Shareholders

    Other

    03989 - CAPITAL ENV


  • Apr 25, 2025
    17:02

    Notification letter and request form to non-registered shareholders

    Other

    03380 - LOGAN GROUP


  • Apr 25, 2025
    17:00

    Notification letter and reply form to registered shareholders

    Other

    03380 - LOGAN GROUP


  • Apr 25, 2025
    16:52

    (1) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (2) PROPOSED GENERAL MANDATE TO BUY BACK SHARES; (3) PROPOSED GENERAL MANDATE TO ISSUE SHARES; AND (4) NOTICE OF ANNUAL GENERAL MEETING

    Re-election or Appointment of Director subject to Shareholders' Approval

    03380 - LOGAN GROUP


  • Apr 24, 2025
    22:35

    MAJOR TRANSACTIONS - (1) DISPOSAL OF 50% EQUITY INTEREST IN HANGZHOU ZHIYAN; AND (2) DISPOSAL OF 50% EQUITY INTEREST IN SUZHOU JINGYU AND 51% EQUITY INTEREST IN SUZHOU ZHUOYU

    Major Transaction

    01813 - KWG GROUP


  • Apr 24, 2025
    21:37

    Letter to Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply Form

    Other

    01515 - CR MEDICAL


  • Apr 24, 2025
    21:36

    Letter to Non-Registered Shareholders - Reminder letter regarding the Arrangement of Electronic Dissemination of Corporate Communications and Reply Form

    Other

    01515 - CR MEDICAL


  • Apr 24, 2025
    21:29

    Notification Letter to Registered/Non-registered Shareholders - Publication of the 2024 Annual Report and the Circular, Notice and Proxy Form of Annual General Meeting

    Other

    01515 - CR MEDICAL


  • ‹
  • 1
  • 2
  • ...
  • 31
  • 32
  • 33
  • ...
  • 478
  • 479
  • ›
  • »

Address

1/F, China Building,
29 Queen's Road Central, Hong Kong
(852) 3693 2688
info@cre8corp.com

Sitemap

  • Listed Companies
  • Disclaimer
  • Privacy Policy

Newsletter

Fill your email and sign up for monthly newsletter to keep updated

© Cre8ir 2026 All right reserved.